What does Dr. Loran Defruyt, Cardioloog do?

Dr. Loran Defruyt, Cardioloog is a specialist medical practice in Dentergem. Private Limited, started on 22 September 2020, 1 establishment.

What is the address of Dr. Loran Defruyt, Cardioloog?

The registered office of Dr. Loran Defruyt, Cardioloog is located at Vijvestraat 5, 8720 Dentergem.

Is Dr. Loran Defruyt, Cardioloog still active?

Yes. According to the CBE (16 September 2026) Dr. Loran Defruyt, Cardioloog is active, legal situation “Normale toestand”, started on 22 September 2020.

Is Dr. Loran Defruyt, Cardioloog registered on Peppol?

Yes, Dr. Loran Defruyt, Cardioloog is registered on the Peppol network with ID 0208:0754724831.

What is the enterprise number of Dr. Loran Defruyt, Cardioloog?

The enterprise number of Dr. Loran Defruyt, Cardioloog is BE0754724831.

When was Dr. Loran Defruyt, Cardioloog founded?

Dr. Loran Defruyt, Cardioloog was founded on 22 September 2020.

Who are the directors of Dr. Loran Defruyt, Cardioloog?

According to the 2025 annual accounts, the directors of Dr. Loran Defruyt, Cardioloog are: Loran Defruyt.

Is Dr. Loran Defruyt, Cardioloog a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 22 September 2020; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Loran Defruyt, Cardioloog make in 2025?

Dr. Loran Defruyt, Cardioloog posted a profit after taxes of € 259,582 in financial year 2025.

What is the revenue of Dr. Loran Defruyt, Cardioloog?

As a small company, Dr. Loran Defruyt, Cardioloog is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 340,797.

Dr. Loran Defruyt, Cardioloog (Private Limited)

Dossier Dr. Loran Defruyt, Cardioloog, printed on 16 September 2026 from databakkes.be/en/0754724831/dr-loran-defruyt-cardioloog. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Loran Defruyt, Cardioloog from Dentergem, company number BE0754724831, closed financial year 2025 with a result of € 259,582 after tax. For that financial year Dr. Loran Defruyt, Cardioloog recorded a gross margin of € 340,797 and equity of € 262,734. Compared with financial year 2024, the result moved from € 245,303 to € 259,582. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 30, 2026.

What it is worth Growing

€ 262,734

▲ 6% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 259,582

▲ 6% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 253,068

▲ 1% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 245,000 paid out

94 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 5,304

▲ 176% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 10 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 158,864

€ 16,119 is repaid this year. At this pace the long-term loan is gone in ≈ 10 years.

Owed to suppliers

€ 5,830

▲ € 5,166 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 1,032

▼ 56% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 193,410 Gross margin 2022: € 193,410 First fiscal year in the series	€ 265,964 Gross margin 2023: € 265,964 ▲ 38% vs 2022 (€ 193,410) Favourable step	€ 324,489 Gross margin 2024: € 324,489 ▲ 22% vs 2023 (€ 265,964) Favourable step	€ 340,797 Gross margin 2025: € 340,797 ▲ 5% vs 2024 (€ 324,489) Favourable step	▲ 5%
Profit after taxes	€ 142,609 Profit after taxes 2022: € 142,609 First fiscal year in the series	€ 197,736 Profit after taxes 2023: € 197,736 ▲ 39% vs 2022 (€ 142,609) Favourable step	€ 245,303 Profit after taxes 2024: € 245,303 ▲ 24% vs 2023 (€ 197,736) Favourable step	€ 259,582 Profit after taxes 2025: € 259,582 ▲ 6% vs 2024 (€ 245,303) Favourable step	▲ 6%
Equity	€ 212,614 Equity 2022: € 212,614 First fiscal year in the series	€ 410,350 Equity 2023: € 410,350 ▲ 93% vs 2022 (€ 212,614) Favourable step	€ 248,152 Equity 2024: € 248,152 ▼ 40% vs 2023 (€ 410,350) Unfavourable step	€ 262,734 Equity 2025: € 262,734 ▲ 6% vs 2024 (€ 248,152) Favourable step	▲ 6%
Total debts	€ 46,180 Total debts 2022: € 46,180 First fiscal year in the series	€ 64,348 Total debts 2023: € 64,348 ▲ 39% vs 2022 (€ 46,180) Unfavourable step	€ 8,951 Total debts 2024: € 8,951 ▼ 86% vs 2023 (€ 64,348) Favourable step	€ 175,172 Total debts 2025: € 175,172 ▲ € 166,221 vs 2024 (€ 8,951) Unfavourable step	▲ € 166,221
Cash	€ 252,553 Cash 2022: € 252,553 First fiscal year in the series	€ 468,064 Cash 2023: € 468,064 ▲ 85% vs 2022 (€ 252,553) Favourable step	€ 250,797 Cash 2024: € 250,797 ▼ 46% vs 2023 (€ 468,064) Unfavourable step	€ 253,068 Cash 2025: € 253,068 ▲ 1% vs 2024 (€ 250,797) Favourable step	▲ 1%
Retained profit	€ 210,114 Retained profit 2022: € 210,114 First fiscal year in the series	€ 407,850 Retained profit 2023: € 407,850 ▲ 94% vs 2022 (€ 210,114) Favourable step	€ 245,652 Retained profit 2024: € 245,652 ▼ 40% vs 2023 (€ 407,850) Unfavourable step	€ 260,234 Retained profit 2025: € 260,234 ▲ 6% vs 2024 (€ 245,652) Favourable step	▲ 6%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 407,500 Dividend 2024: € 407,500 Unchanged (€ 0) Unchanged	€ 245,000 Dividend 2025: € 245,000 ▼ 40% vs 2024 (€ 407,500) Unchanged	▼ 40%
Bank debt	€ 34 Bank debt 2022: € 34 First fiscal year in the series	€ 0 Bank debt 2023: € 0 ▼ 100% vs 2022 (€ 34) Favourable step	€ 0 Bank debt 2024: € 0 Unchanged (€ 0) Unchanged	€ 158,864 Bank debt 2025: € 158,864 Unchanged (€ 0) Unfavourable step
Balance sheet total	€ 258,794 Balance sheet total 2022: € 258,794 First fiscal year in the series	€ 474,697 Balance sheet total 2023: € 474,697 ▲ 83% vs 2022 (€ 258,794) Unchanged	€ 257,103 Balance sheet total 2024: € 257,103 ▼ 46% vs 2023 (€ 474,697) Unchanged	€ 437,906 Balance sheet total 2025: € 437,906 ▲ 70% vs 2024 (€ 257,103) Unchanged	▲ 70%

Key figures of Dr. Loran Defruyt, Cardioloog, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Loran Defruyt, Cardioloog?

What happened at Dr. Loran Defruyt, Cardioloog in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 30, 2026 New annual accounts for financial year 2025: profit of € 259,582 (▲ 6% vs 2024). Source: NBB ↗
Sep 22, 2020 New establishment in Tielt. KBO
Sep 22, 2020 Start of the company according to the CBE. KBO
2020 Loran Defruyt became a director. NBB

In short

From € 142,609 profit in 2022 to € 259,582 profit in 2025.

Paid € 259,995 in corporate taxes since 2022.

Best year ever: 2025, with € 259,582 profit.

Paid out € 652,500 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Loran Defruyt, Cardioloog? We notify you, reason included.

Follow Dr. Loran Defruyt, Cardioloog

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Loran Defruyt

Dr. Loran Defruyt, Cardioloog

Behind Dr. Loran Defruyt, Cardioloog is Loran Defruyt.

See the full network in the app

Directors

According to the 2025 annual accounts

Loran Defruyt

Director

since 2020

Establishments

Establishment units

Physical locations of this company

Registered office

Vijvestraat 5

8720 Dentergem

2.307.385.619

Bruggestraat 84

8700 Tielt

Active since 22 September 2020

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

Dr. Lien De Smet, Dermatoloog

€ 232,107 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0754.724.831
VAT number: BE 0754.724.831
Registered office: Vijvestraat 5, 8720 Dentergem
Names & denominations: Dr. Loran Defruyt, Cardioloog
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 22 September 2020
Peppol: Active · Active since 15 Oct 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗